Dark genome biotech RyboDyn deepens partnership with world-leading cancer immunotherapy center to validate novel oncology ...

Lantern's proprietary RADR ® platform has grown during Q1 2025 to approximately 200 billion oncology-focused data points across multiple sources (proprietary, collaborative and public) of oncology, ...

China is outpacing the U.S. in critical technologies—preserving American leadership demands urgent, systemic, and strategic ...

Mission Prep, part of the AMFM Healthcare family of programs, announces the launch of LAB: Learn. Adapt. Become., a 6- to 12-week residential program created to turn the long summer stretch into a ...

Janux Therapeutics, Inc. (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell ...

The Tow Center for Digital Journalism interviewed news and tech industry representatives about AI’s impact on platforms and ...

Space Solar's successful "Cassidi" project marks a significant step towards delivering continuous, clean energy from space.

Innovative nanoparticles from OHSU improve ultrasound cancer treatments, combining mechanical and drug therapies to enhance ...